glp-1 agonist in esrd Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis π Real Hope for Kidney
Description
Brandt SJ, Mller TD, DiMarchi RD, et al
H.HoeferJ.BolzS
K.SimmonsJ
The price is expected to collapse from CNY 2,0004,000 per month down to CNY 150350 within five years of generic entry
Preclinical data demonstrate that GLP-1 and GLP-1RAs exert anti-inflammatory effects, preserve gut barrier integrity, and modulate the microbiome
